Monthly information on share capital and company voting rights
Cellectis (Euronext Growth: CLLS) published its monthly information on share capital and voting rights as of 09/30/2025. The company reports a total number of shares of 100,325,229 and a total number of voting rights of 89,413,272. The disclosure follows Article 223-16 of the General Regulation of the French financial markets authority and lists investor and media contacts for further information.
Cellectis ( Euronext Growth: CLLS ) ha pubblicato le informazioni mensili sul capitale sociale e sui diritti di voto al 30/09/2025. L'azienda riporta un numero totale di azioni pari a 100.325.229 e un numero totale di diritti di voto pari a 89.413.272. La comunicazione segue l'articolo 223-16 del Regolamento generale dell'Autorité des marchés financiers francese e include contatti per investitori e media per ulteriori informazioni.
Cellectis (Euronext Growth: CLLS) publicó su información mensual sobre el capital social y los derechos de voto al 30/09/2025. La empresa informa un número total de acciones de 100,325,229 y un número total de derechos de voto de 89,413,272. La divulgación se realiza conforme al artículo 223-16 del Reglamento General de la Autoridad de Mercados Financieros francesa y enumera contactos para inversores y medios para más información.
Cellectis (Euronext Growth: CLLS) 2025년 9월 30일 기준의 자본금 및 의결권에 관한 월간 정보를 공개했습니다. 회사는 총 주식 수가 100,325,229주이며 의결권의 총수가 89,413,272개라고 보고합니다. 이 공시는 프랑스 금융시장청의 일반 규정 제223-16조에 따라 작성되며 추가 정보로 투자자 및 언론 연락처를 제공합니다.
Cellectis (Euronext Growth: CLLS) a publié ses informations mensuelles sur le capital social et les droits de vote au 30/09/2025. La société indique un nombre total d'actions de 100 325 229 et un nombre total de droits de vote de 89 413 272. Cette divulgation respecte l'article 223-16 du règlement général de l'Autorité des marchés financiers et comporte les contacts investisseurs et médias pour de plus amples informations.
Cellectis (Euronext Growth: CLLS) veröffentlichte seine monatlichen Informationen zum Kapital und zu den Stimmrechten zum 30.09.2025. Das Unternehmen meldet eine gesamte Anzahl von Aktien von 100.325.229 und eine gesamte Anzahl von Stimmrechten von 89.413.272. Die Offenlegung erfolgt gemäß Artikel 223-16 der Allgemeinen Vorschriften der französischen Finanzmarktaufsicht und führt Kontakte zu Investoren und Medien für weitere Informationen auf.
Cellectis (Euronext Growth: CLLS) نشرت معلوماتها الشهرية حول رأس المال والإجماع التصويت عند تاريخ 30/09/2025. الشركة تبلغ عن إجمالي عدد الأسهم بمقدار 100,325,229 و< b>إجمالي عدد حقوق التصويت بمقدار 89,413,272. ويتبع الإفصاح المادة 223-16 من النظام التنظيمي العام لهيئة الأسواق المالية الفرنسية ويذكر جهات اتصال للمستثمرين ووسائل الإعلام لمزيد من المعلومات.
Cellectis (Euronext Growth: CLLS) 发布了截至 2025/09/30 的股本与表决权月度信息。公司报告 总股本数量为 100,325,229 股，总表决权数量为 89,413,272 股。该披露遵循法国金融市场监管机构通用条例第 223-16 条，并列出投资者及媒体联系方式以获取更多信息。
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Oct. 07, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 09/30/2025 | 100,325,229 | 89,413,272 |
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Attachment
FAQ
What are Cellectis's total shares and voting rights as of 09/30/2025 (CLLS)?
Which listing and ISIN apply to Cellectis in the 09/2025 share capital update?
Where can investors get more information about Cellectis share capital (CLLS)?
Does the 09/30/2025 release for Cellectis indicate any capital changes or transactions?
Which regulatory article governs Cellectis's monthly share capital disclosure?
Who are the media contacts listed in Cellectis's September 2025 voting rights notice?
